Oncology Drugs Market Size, Share & Trends Analysis Report By Indication (Lung, Breast, Colorectal, Prostate, Stomach, Liver), By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa), And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1. Methodology and Scope
                1.1. Market Segmentation & Scope
                1.2. Market Definition
                1.3. Information Procurement
                    1.3.1. Purchased Database
                    1.3.2. Million Insights’ Internal Database
                    1.3.3. Secondary Sources & Third-Party Perspectives
                    1.3.4. Primary Research
                1.4. Information Analysis
                    1.4.1. Data Analysis Models
                1.5. Market Formulation & Data Visualization
                1.6. Data Validation & Publishing
Chapter 2. Executive Summary
                2.1. Market Outlook
                2.2. Indication Outlook
                2.3. Regional Outlook
                2.4. Competitive Insights
Chapter 3. Oncology Drugs Market Variables, Trends & Scope
                3.1. Market Introduction
                3.2. Penetration & Growth Prospect Mapping
                3.3. Industry Value Chain Analysis
                    3.3.1. Sales/Retail Channel Analysis
                    3.3.2. Profit Margin Analysis
                3.4. Market Dynamics
                    3.4.1. Market Driver Analysis
                    3.4.2. Market Restraint Analysis
                    3.4.3. Industry Challenges
                    3.4.4. Industry Opportunities
                3.5. Business Environment Analysis
                    3.5.1. Industry Analysis - Porter’s
                        3.5.1.1. Supplier Power
                        3.5.1.2. Buyer Power
                        3.5.1.3. Substitution Threat
                        3.5.1.4. Threat from New Entrant
                        3.5.1.5. Competitive Rivalry
                3.6. Roadmap of Oncology Drugs Market
                3.7. Market Entry Strategies
                3.8. Impact of COVID-19
Chapter 4. Consumer Behavior Analysis
                4.1. Consumer Trends and Preferences
                4.2. Factors Affecting Buying Decision
                4.3. Consumer Product Adoption
                4.4. Observations & Recommendations
Chapter 5. Oncology Drugs Market: Indication Estimates & Trend Analysis
                5.1. Indication Movement Analysis & Market Share, 2020 & 2028
                5.2. Lung
                    5.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.3. Breast
                    5.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.4. Colorectal
                    5.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.5. Prostate
                    5.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.6. Stomach
                    5.6.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.7. Liver
                    5.7.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.8. Others
                    5.8.1. Market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6. Oncology Drugs Market: Regional Estimates & Trend Analysis
                6.1. Regional Movement Analysis & Market Share, 2020 & 2028
                6.2. North America
                    6.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.2.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.2.3. U.S.
                        6.2.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.2.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.3. Europe
                    6.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.3. Germany
                        6.3.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.4. France
                        6.3.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.4.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.5. U.K.
                        6.3.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.5.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.4. Asia Pacific
                    6.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.4.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.4.3. China
                        6.4.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.4.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.4.4. India
                        6.4.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.4.4.2. Market estimates and forecast, by Indication2017 - 2028 (USD Million)
                6.5. Central & South America
                    6.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.5.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.5.3. Brazil
                        6.5.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.5.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.6. Middle East & Africa
                    6.6.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.6.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.6.3. South Africa
                        6.6.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.6.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
Chapter 7. Competitive Analysis
                7.1. Key global players, recent developments & their impact on the industry
                7.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                7.3. Vendor Landscape
                    7.3.1. Key company market share analysis, 2020
Chapter 8. Company Profiles
                8.1. Merck
                    8.1.1. Company Overview
                    8.1.2. Financial Performance
                    8.1.3. Product Benchmarking
                    8.1.4. Strategic Initiatives
                8.2. Novartis
                    8.2.1. Company Overview
                    8.2.2. Financial Performance
                    8.2.3. Product Benchmarking
                    8.2.4. Strategic Initiatives
                8.3. JOHNSON & JOHNSON
                    8.3.1. Company Overview
                    8.3.2. Financial Performance
                    8.3.3. Product Benchmarking
                    8.3.4. Strategic Initiatives
                8.4. Pfizer
                    8.4.1. Company Overview
                    8.4.2. Financial Performance
                    8.4.3. Product Benchmarking
                    8.4.4. Strategic Initiatives
                8.5. AstraZeneca
                    8.5.1. Company Overview
                    8.5.2. Financial Performance
                    8.5.3. Product Benchmarking
                    8.5.4. Strategic Initiatives
                8.6. Eli Lilly
                    8.6.1. Company Overview
                    8.6.2. Financial Performance
                    8.6.3. Product Benchmarking
                    8.6.4. Strategic Initiatives
                8.7. Hoffmann-La Roche
                    8.7.1. Company Overview
                    8.7.2. Financial Performance
                    8.7.3. Product Benchmarking
                    8.7.4. Strategic Initiatives
                8.8. AbbVie
                    8.8.1. Company Overview
                    8.8.2. Financial Performance
                    8.8.3. Product Benchmarking
                    8.8.4. Strategic Initiatives
                8.9. Sanofi
                    8.9.1. Company Overview
                    8.9.2. Financial Performance
                    8.9.3. Product Benchmarking
                    8.9.4. Strategic Initiatives
                8.10. GSK
                    8.10.1. Company Overview
                    8.10.2. Financial Performance
                    8.10.3. Product Benchmarking
                    8.10.4. Strategic Initiatives

List of Tables

1. Oncology drugs market - Key market driver analysis
2. Oncology drugs market - Key market restraint analysis
3. Global oncology drugs market revenue estimates and forecast by Lung, from 2017 - 2028 (USD Million)
4. Global oncology drugs market revenue estimates and forecast by Breast, from 2017 - 2028 (USD Million)
5. Global oncology drugs market revenue estimates and forecast by Colorectal, from 2017 - 2028 (USD Million)
6. Global oncology drugs market revenue estimates and forecast by Prostate, from 2017 - 2028 (USD Million)
7. Global oncology drugs market revenue estimates and forecast by Stomach, from 2017 - 2028 (USD Million)
8. Global oncology drugs market revenue estimates and forecast by Liver, from 2017 - 2028 (USD Million)
9. Global oncology drugs market revenue estimates and forecast by Others, from 2017 - 2028 (USD Million)
10. Global oncology drugs market estimates and forecast, by region 2017 - 2028 (USD Million)
11. Global oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
12. North America oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
13. North America oncology drugs market revenue estimates and forecast, by Indication, 2017 - 2028 (USD Million)
14. U.S. oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
15. U.S. oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
16. Europe oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
17. Europe oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
18. Germany oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
19. Germany oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
20. France oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
21. France oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
22. U.K. oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
23. U.K. oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
24. Asia Pacific oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
25. Asia Pacific oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
26. China oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
27. China oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
28. India oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
29. India oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
30. Central & South America oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
31. Central & South America oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
32. Brazil oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
33. Brazil oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
34. Middle East & Africa oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
35. Middle East & Africa oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
36. South Africa oncology drugs market estimates and forecast, 2017 - 2028 (USD Million)
37. South Africa oncology drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
38. Vendor landscape

List of Figures

1. Oncology drugs market snapshot
2. Oncology drugs market segmentation & scope
3. Oncology drugs market penetration & growth prospect mapping
4. Oncology drugs market value chain analysis
5. Oncology drugs market dynamics
6. Oncology drugs market Porter's analysis
7. Oncology drugs market: Indication movement analysis
8. Oncology drugs market: Regional movement analysis